Lertrit P, Noer A S, Jean-Francois M J, Kapsa R, Dennett X, Thyagarajan D, Lethlean K, Byrne E, Marzuki S
Department of Biochemistry, Monash University, Clayton, Victoria, Australia.
Am J Hum Genet. 1992 Sep;51(3):457-68.
The molecular lesions in two patients exhibiting classical clinical manifestations of MELAS (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes) syndrome have been investigated. A recently reported disease-related A----G base substitution at nt 3243 of the mtDNA, in the DHU loop of tRNA(Leu), was detected by restriction-enzyme analysis of the relevant PCR-amplified segment of the mtDNA of one patient but was not observed, by either restriction-enzyme analysis or nucleotide sequencing, in the other. To define the molecular lesion in the patient who does not have the A----G base substitution at nt 3243, the total mitochondrial genome of the patient has been sequenced. An A----G base substitution at nt 11084, leading to a Thr-to-Ala amino acid replacement in the ND4 subunit of the respiratory complex I, is suggested to be a disease-related mutation.
对两名表现出线粒体脑肌病伴乳酸血症和卒中样发作(MELAS)综合征典型临床表现的患者的分子病变进行了研究。通过对一名患者线粒体DNA(mtDNA)相关PCR扩增片段的限制性酶切分析,检测到了最近报道的位于tRNA(Leu)的DHU环中mtDNA第3243位核苷酸的A→G碱基替换,但通过限制性酶切分析或核苷酸测序,在另一名患者中均未观察到该替换。为了确定在第3243位核苷酸处没有A→G碱基替换的患者的分子病变,对该患者的整个线粒体基因组进行了测序。第11084位核苷酸的A→G碱基替换导致呼吸复合体I的ND4亚基中苏氨酸被丙氨酸取代,提示这是一种与疾病相关的突变。